Journal of International Oncology››2015,Vol. 42››Issue (10): 759-761.doi:10.3760/cma.j.issn.1673-422X.2015.10.011
Previous ArticlesNext Articles
Luo Junqian, Dong Suming, Zhang Fan, Yang Xiaofeng
Online:
2015-10-08Published:
2015-09-08Contact:
Yang Xiaofeng E-mail:yxfylq@163.comLuo Junqian, Dong Suming, Zhang Fan, Yang Xiaofeng. Progress of phage display technology in cancer[J]. Journal of International Oncology, 2015, 42(10): 759-761.
[1] 陈记稷, 胡智渊, 张彦琼, 等. 肿瘤血管靶向噬菌体展示肽的研究进展[J]. 医学分子生物学杂志, 2006, 3(2): 149-152. [2] Deutscher SL. Phage display in molecular imaging and diagnosis of cancer[J]. Chem Rev, 2010, 110(5): 3196-3211. [3] Lee TY, Lin CT, Kuo SY, et al. Peptidemediated targeting to tumor blood vessels of lung cancer for drug delivery[J]. Cancer Res, 2007, 67(22): 10958-10965. [4] Li Y, Lei Y, Wagner E, et al. Potent retroinverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells[J]. Bioconjug Chem, 2013, 24(1): 133-143. [5] Zhi M, Wu KC, Hao ZM, et al. Screening of specific binding peptide targeting blood vessel of human esophageal cancer in vivo in mice[J]. Chin Med J (Engl), 2011, 124(4): 581-585. [6] Xiao M, Hong Z, Sun L, et al. TMTP1, a novel tumorhoming peptide, specifically targets hematological malignancies and their metastases[J]. J Huazhong Univ Sci Technolog Med Sci, 2011, 31(5): 608-613. [7] Lowery A, Onishko H, Hallahan DE, et al. Tumortargeted delivery of liposomeencapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors[J]. J Control Release, 2011, 150(1): 117-124. [8] Potala S, Verma RS. Targeting head and neck squamous cell carcinoma using a novel fusion toxindiphtheria toxin/HN1[J].Mol Biol Rep, 2011, 38(2): 1389-1397. [9] Arap W, Pasqualini R, Ruoslahti E. Chemotherapy targeted to tumor vasculature[J]. Curr Opin Oncol, 1998, 10(6): 560-565. [10] Curnis F, Sacchi A, Borgna L, et al. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)[J]. Nat Biotechnol, 2000, 18(11): 1185-1190. [11] Essler M, Grtner FC, Neff F, et al. Therapeutic efficacy and toxicity of 225Aclabelled vs 213 Bilabelled tumourhoming peptides in a preclinical mouse model of peritoneal carcinomatosis[J]. Eur J Nucl Med Mol Imaging, 2012, 39(4): 602-612. [12] 张家禾, 左伟勇, 洪伟鸣, 等. 噬菌体展示技术及其在抗体制备中应用的研究进展[J]. 南昌大学学报:医学版, 2014, 54(2): 83-88. [13] Bi Q, Tan T, Xiang X, et al. Detection of breast cancer related antigens through cDNA phage displayed protein microarray[J]. Biol Chem, 2010, 391(7): 831-835. [14] Ye Y, Chen X. Integrin targeting for tumor optical imaging[J]. Theranostics, 2011, 1: 102-126. [15] Gao J, Chen K, Xie R, et al. In vivo tumortargeted fluorescence imaging using nearinfrarednearinfrared noncadmium quantum dots[J]. Bioconjug Chem, 2010, 21(4): 604-609. [16] 强荣兵, 张楠楠, 魏丽丽, 等. 噬菌体展示技术及其在肿瘤研究中的应用[J]. 中国生物工程杂志, 2009, 29(9): 81-86. [17] Silman NJ. World influenza congress Europe 2009[J]. Expert Rev Vaccines, 2010, 9(3): 273-275 [18] Bretscher MT, Althaus CL, Müller V, et al. Recombination in HIV and the evolution of drug resistance: for better or for worse?[J]. Bioessays, 2004, 26(2): 180-188. [19] 杨柳, 沈克飞, 郑华, 等. 噬菌体展示颗粒疫苗的研究进展[J]. 中国生物制品学杂志, 2013, 26(4): 569-573. [20] 刘文俊, 赵祖国, 吕世静, 等. 噬菌体展示技术在抗体亲和力成熟中的应用进展[J]. 免疫学杂志, 2012, 28(7): 628-632. [21] 黄娴. 利用噬菌体展示技术发现针对血型抗原的单链抗体[D]. 上海:华东师范大学, 2012. [22] 张自强, 杨晓峰, 刘杰昊. 肽类药物在肿瘤治疗中的研究进展[J]. 国际肿瘤学杂志, 2015, 42(1): 52-55. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||